119 related articles for article (PubMed ID: 37165991)
1. [Anthra-cycline-Induced Cardiotoxicity: the Role of Genetic Predictors].
Kopeva KV; Grakova EV; Shilov SN; Popova AA; Berezikova EN; Neupokoeva MN; Ratushnyak ET; Teplyakov AT
Kardiologiia; 2023 May; 63(4):22-28. PubMed ID: 37165991
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors.
Kopeva KV; Grakova EV; Shilov SN; Berezikova EN; Popova AA; Neupokoeva MN; Ratushnyak ET; Teplyakov AT
Acta Cardiol; 2022 Nov; 77(9):805-814. PubMed ID: 34783301
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic role of p53 gene polymorphism in risk assessment of anthracycline-induced cardiotoxicity].
Shilov SN; Teplyakov AT; Popova AA; Berezikova EN; Neupokoeva MN; Grakova EV; Valeeva AM; Tuleutaev SM
Kardiologiia; 2019 Aug; 59(7S):15-22. PubMed ID: 31441737
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms rs4673 and rs28714259 in predicting anthracycline-mediated cardiotoxicity in patients with breast cancer.
Gvaldin GD; Timoshkina TN; Vladimirova L; Svetitskaya SY; Vaschenko VL
Klin Onkol; 2021; 34(6):463-466. PubMed ID: 34911332
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix remodeling in anthracycline-induced cardiotoxicity: What place on the pedestal?
Grakova EV; Shilov SN; Kopeva KV; Berezikova EN; Popova AA; Neupokoeva MN; Ratushnyak ET; Teplyakov AT
Int J Cardiol; 2022 Mar; 350():55-61. PubMed ID: 35007649
[TBL] [Abstract][Full Text] [Related]
6. Anthracycline-Induced Cardiotoxicity: The Role of Endothelial Dysfunction.
Grakova EV; Shilov SN; Kopeva KV; Berezikova EN; Popova AA; Neupokoeva MN; Ratushnyak ET; Teplyakov AT
Cardiology; 2021; 146(3):315-323. PubMed ID: 33596565
[TBL] [Abstract][Full Text] [Related]
7. Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease.
El-Lebedy D
Cardiovasc Diabetol; 2018 Jul; 17(1):97. PubMed ID: 29973202
[TBL] [Abstract][Full Text] [Related]
8. Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.
Cascales A; Pastor-Quirante F; Sánchez-Vega B; Luengo-Gil G; Corral J; Ortuño-Pacheco G; Vicente V; de la Peña FA
Oncologist; 2013; 18(4):446-53. PubMed ID: 23576480
[TBL] [Abstract][Full Text] [Related]
9. Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia.
He H; Xu YJ; Yin JY; Li X; Qu J; Xu XJ; Liu ZG; Zhou F; Zhai M; Li Y; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):400-7. PubMed ID: 24684492
[TBL] [Abstract][Full Text] [Related]
10. Association of
Chavoshi R; Khalifeh Zadeh Kaleybar SB
Horm Mol Biol Clin Investig; 2020 Jun; 41(4):. PubMed ID: 32598309
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion.
Holliday DL; Hughes S; Shaw JA; Walker RA; Jones JL
Breast Cancer Res; 2007; 9(5):R67. PubMed ID: 17922906
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms.
Lambrinoudaki I; Chatzivasileiou P; Stergiotis S; Armeni E; Rizos D; Kaparos G; Augoulea A; Alexandrou A; Georgiopoulos G; Laina A; Stamatelopoulos K
Heart Vessels; 2018 Dec; 33(12):1434-1444. PubMed ID: 29948131
[TBL] [Abstract][Full Text] [Related]
13. The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition.
Berkman AM; Hildebrandt MAT; Landstrom AP
Clin Genet; 2021 Aug; 100(2):132-143. PubMed ID: 33871046
[TBL] [Abstract][Full Text] [Related]
14. The joint effect of the endothelin receptor B gene (EDNRB) polymorphism rs10507875 and nitric oxide synthase 3 gene (NOS3) polymorphism rs869109213 in Slovenian patients with type 2 diabetes mellitus and diabetic retinopathy.
Bregar D; Cilenšek I; Mankoč S; Reschner A; Petrovič D; Globočnik Petrovič M
Bosn J Basic Med Sci; 2018 Feb; 18(1):80-86. PubMed ID: 28817788
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.
Krajinovic M; Elbared J; Drouin S; Bertout L; Rezgui A; Ansari M; Raboisson MJ; Lipshultz SE; Silverman LB; Sallan SE; Neuberg DS; Kutok JL; Laverdière C; Sinnett D; Andelfinger G
Pharmacogenomics J; 2016 Nov; 16(6):530-535. PubMed ID: 26345518
[TBL] [Abstract][Full Text] [Related]
16. [Association of AGT, ACE, NOS3, TNF, MMP9, CYBA polymorphism with subclinical arterial wall changes].
Akopyan AA; Kirillova KI; Strazhesko ID; Samokhodskaya LM; Orlova YA
Kardiologiia; 2021 Mar; 61(3):57-65. PubMed ID: 33849420
[TBL] [Abstract][Full Text] [Related]
17. The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis.
Melchers I; Blaschke S; Hecker M; Cattaruzza M
Arthritis Rheum; 2006 Oct; 54(10):3144-51. PubMed ID: 17009241
[TBL] [Abstract][Full Text] [Related]
18. No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients.
Weiss J; Fränkl SA; Flammer J; Grieshaber MC; Hollo G; Teuchner B; Haefeli WE
Mol Vis; 2012; 18():2174-81. PubMed ID: 22919264
[TBL] [Abstract][Full Text] [Related]
19. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 Codon72 SNP in breast cancer risk and anthracycline resistance.
Arfaoui A; Douik H; Kablouti G; Chaaben AB; Handiri N; Zid Z; Ouni N; Zouiouch F; Ayari F; Mamoughli T; Bouassida J; Abazza H; Harzallaha L; Guemira F
Anticancer Res; 2015 Mar; 35(3):1763-9. PubMed ID: 25750340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
